Bibliometric analysis on breast cancer research by GoPubMed

doi:10.3877/cma.j.issn.1673-5250.2017.05.015

Objective

To study the feasibility of GoPubMed to research status on breast cancer by bibliometric analysis method.

Methods

According to bibliometric analysis method, " breast neoplasms" " breast cancer" " breast carcinoma" and " mammary neoplasms" were selected as docuterms, 98 462 literatures on breast cancer research, which were in accordance with the inclusion and exclusion criteria of this study, from January 1, 2004 to April 29, 2016 in PubMed database were included as study subjects. The research situation and development trend of research on breast cancer were studied by statistical analysis of high-frequency key words and published year, country, city, the distribution of journals and the research trend of breast cancer.

Results

The number of published literatures of research on breast cancer showed a gradual upward trend included in PubMed database from 2004 to 2015. United States and China were the countries with the top two largest amount of published literatures on breast cancer research in PubMed database within the time of literature retrieval among 98 462, areas and cities with large amount of published literatures were concentrated in the countries of North America and Europe. Beijing and Shanghai were among the top 10 cities with a large amount of published literatures on breast cancer research. Magazines which published a large amount of literatures on breast cancer research were concentrated in magazines published by countries in Europe and the United States. Only one kind of magazines published in Asia was among the top 10 magazines with a large amount of published literatures on breast cancer research. At present, the breast cancer research mainly focused on the oneset age, gene mutation and protein and so on.

Conclusions

GoPubMed is a useful tool to research the current situation and development trend on breast cancer. The studies of breast cancer are mainly concentrated in countries of North America and Europe. Research on breast cancer in China is relatively weak besides Beijing and Shanghai.

Key words: Breast neoplasms, Bibliometrics, Amount of published literatures, Geographical distribution, Female

表1 98 462篇乳腺癌相关研究文献中，前20个乳腺癌相关研究的高频主题词及其出现频率比较

高频主题词	词频(次)
breast neoplasms	90 038
humans	74 011
female	66 298
patients	44 827
neoplasms	38 490
middle aged	27 861
adult	23 262
evaluation studies as topic	22 814
woman	22 565
aged	20 998
research report	19 633
diagnosis	17 128
survival	16 676
proteins	16 377
genes	16 143
neoplasm metastasis	15 862
carcinoma	14 891
tissues	14 573
cell line, tumor	14 481
animals	13 604

表1 98 462篇乳腺癌相关研究文献中，前20个乳腺癌相关研究的高频主题词及其出现频率比较

高频主题词	词频(次)
breast neoplasms	90 038
humans	74 011
female	66 298
patients	44 827
neoplasms	38 490
middle aged	27 861
adult	23 262
evaluation studies as topic	22 814
woman	22 565
aged	20 998
research report	19 633
diagnosis	17 128
survival	16 676
proteins	16 377
genes	16 143
neoplasm metastasis	15 862
carcinoma	14 891
tissues	14 573
cell line, tumor	14 481
animals	13 604

图1 98 462篇乳腺癌相关研究文献的年份分布情况及其发文量比较

图2 98 462篇乳腺癌相关研究文献中，发文量前10位的国家分布情况及其发文量比较

图3 98 462篇乳腺癌相关研究文献的发表地区可视化地图

图4 98 462篇乳腺癌研究相关文献中，发文量前10位的城市分布情况及其发文量比较

图5 98 462篇乳腺癌相关研究文献中，发文量前10位的期刊及其发文量比较

[1]	韩雪，谢梦，赵佳，等. 2002－2012年上海市杨浦区女性人群乳腺癌的发病和生存情况分析[J]. 中华疾病控制杂志，2015, 19(7): 708-711.
[2]	陈万青，郑荣寿. 中国女性乳腺癌发病死亡和生存状况[J]. 中国肿瘤临床，2015, 42(13): 668-674.
[3]	冯新熠，陆苏，刘红. 亚洲国家及地区乳腺癌筛查指南的发展和实践[J]. 中国肿瘤临床，2015, 42(8): 451-454.
[4]	史双，路潜，杨萍，等. 乳腺癌就诊延误的研究现状[J]. 中华护理杂志，2015, 50(4): 468-471.
[5]	陈颖，史春颖，杨予川，等. FGFR2基因多态性与黑龙江地区女性乳腺癌相关性的研究[J]. 哈尔滨医科大学学报，2016, 50(1): 44-45.
[6]	包睿楠，张瑞明. 乳腺癌相关生物因子的研究进展[J]. 世界最新医学信息文摘，2016, 16(8): 62-64.
[7]	张雪梅，李宏江，王达，等. 自噬相关基因ATG2B、ATG4D、ATG9B在浸润性乳腺癌中的表达及临床意义[J]. 四川大学学报(医学版), 2016, 47(2): 184-188.
[8]	Zhang Z, Li L, Cao S, et al. Gene delivery of TIPE2 inhibits breast cancer development and metastasis via CD₈^＋，T and NK cell-mediated antitumor responses[J]. Mol Immunol, 2017, 85: 230-237.
[9]	Strati A, Markou A, Parisi C, et al. Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR[J]. BMC Cancer, 2011, 11(1): 422.
[10]	Tandia M, Mhiri A, Paule B, et al. Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study[J]. Cancer Chemother Pharmacol, 2017, 79(4): 759-766.
[11]	Chou YT, Winn AN, Rosenstein DL, et al. Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis[J]. Pharmacoepidemiol Drug Saf, 2017, 26(6): 676-684.
[12]	Porto-Mascarenhas EC, Assad DX, Chardin H, et al. Salivary biomarkers in the diagnosis of breast cancer: a review[J]. Crit Rev Oncol Hematol, 2017, 110: 62-73.
[13]	Li C，ed. Breast cancer epidemiology[M]. Springer Press: New York, 2010: 331.
[14]	Chen W, Song H, Zhong R, et al. Risk of GWAS-identified genetic variants for breast cancer in a Chinese population: a multiple interaction analysis[J]. Breast Cancer Res Treat, 2013, 142(3): 637-644.
[15]	廖宁，王坤，吴一龙. NCCN乳腺癌临床指引(2003版)[J]. 循证医学，2003, 3(3): 167-192.
[16]	Li T, Mello-Thoms C, Brennan PC. Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence[J]. Breast Cancer Res Treat, 2016, 159(3): 395-406.
[17]	周斌，刘世伟，高国璇，等. 2016年NCCN乳腺癌临床实践指南(第1版)更新与解读[J]. 中国实用外科杂志，2016, 36(10): 1066-1072.

[1]	Yaping Jia, Shu'e Zeng. Ultrasound and pathological characteristics of breast metaplastic carcinoma containing squamous cell carcinoma components[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 844-848.
[2]	Wei Tang, Rongquan He, Suning Huang. Application of deep learning in imaging for diagnosis, treatment and prognosis prediction of breast cancer[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 323-328.
[3]	Xia Kang, Hao Tian, Jin Qian, Yuan Gao, Hongming Miao, Xiaowei Qi. Osteorin attenuates osteolysis during bone metastasis of cancers through inhibiting osteoclastogenesis[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 329-339.
[4]	Xiaoli Yi, Shasha Hu, Yan Zhang. Impact of HER-2 low expression on response of neoadjuvant chemotherapy and prognosis in breast cancer patients[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 340-346.
[5]	Jie Shi, Yuntao Li, Haiyan Gao. Prognosis of node-positive luminal A breast cancer patients with neoadjuvant and adjuvant chemotherapy and influencing factors[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 353-361.
[6]	Jiaxuan Liu, Binghe Xu. Annual advancement of clinical research on breast cancer in China[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 259-265.
[7]	Chengcai Yao, Changchun Liu, Wenjian Huang, Ming Chen. Single-port non-lipolysis fluorescence-guided laparoscopy for axillary lymph node biopsy in early breast cancer[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 266-271.
[8]	Bohui Shi, Xiping Ding, Lian Wang, Rong Li, Pingli Guo, Jing Qi, Yao Chen, Na Hao, Yu Ren. Summary of best evidences for prevention and treatment of subcutaneous seroma after breast cancer surgery[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 277-284.
[9]	Minrong Ma, Cong Li, Qin Zhou. Current research status of treatment of cervical cancer[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 497-504.
[10]	Changsheng Lin, Jun Zhan, Xue Xiao. Genetic testing and precision molecular targeted therapy in diagnosis and treatment of epithelial ovarian caner[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 505-510.
[11]	Qingyan Yan, Xiaomei Yong, Hong Luo, Min Du. Prognostic factors and survival analysis of multicenter elderly patients with metastatic breast cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 636-638.
[12]	Zhiming Li, Chenming Guo, Xiaochen Zhuang, Xueqin Hou, Junxi Gao. Comparative study of qualitative and quantitative indicators of contrast-enhanced ultrasound in early breast cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 639-643.
[13]	Hongbo Qu, Fang Zhu, Zhe Xu, Nan Wu, Jianhuai He, Xianming Wang. Application of subclavian lymph node dissection through intermuscular approach in locally advanced breast cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 510-513.
[14]	Shan Chen, Zhiqiang Hu, Yueming Zhang, Ding Tang, Meng Li, Shuai Zhao. Expression of Orai1 and Orai3 in breast cancer and their correlation with pathological indexes[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 514-517.
[15]	Qiaoqiao Yang, Yan Tong, Hong Wang, Dayang Xie, Yuting Zhang, Qingtao Zhang, Qian Yu, Xiaolin Zhao, Xueying Cao, Jianhui Zhou. Artificial kidney research: a bibliometric analysis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(05): 241-247.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export